Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Total Liabilities (2016 - 2025)

Proto Labs (PRLB) has disclosed Total Liabilities for 15 consecutive years, with $89.5 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 21.98% to $89.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $89.5 million through Dec 2025, up 21.98% year-over-year, with the annual reading at $89.5 million for FY2025, 21.98% up from the prior year.
  • Total Liabilities hit $89.5 million in Q4 2025 for Proto Labs, down from $92.1 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $121.0 million in Q1 2021 to a low of $73.0 million in Q2 2024.
  • Historically, Total Liabilities has averaged $93.4 million across 5 years, with a median of $95.3 million in 2022.
  • Biggest five-year swings in Total Liabilities: surged 33.94% in 2021 and later fell 26.27% in 2023.
  • Year by year, Total Liabilities stood at $100.1 million in 2021, then grew by 4.43% to $104.5 million in 2022, then dropped by 26.27% to $77.1 million in 2023, then dropped by 4.8% to $73.4 million in 2024, then rose by 21.98% to $89.5 million in 2025.
  • Business Quant data shows Total Liabilities for PRLB at $89.5 million in Q4 2025, $92.1 million in Q3 2025, and $78.5 million in Q2 2025.